SteelPeak Wealth LLC Trims Position in Astrana Health, Inc. (NASDAQ:ASTH)

SteelPeak Wealth LLC trimmed its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 20.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 541,984 shares of the company’s stock after selling 138,000 shares during the period. Astrana Health makes up about 0.7% of SteelPeak Wealth LLC’s portfolio, making the stock its 28th biggest position. SteelPeak Wealth LLC owned about 0.96% of Astrana Health worth $17,089,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in ASTH. Janus Henderson Group PLC acquired a new position in Astrana Health during the third quarter valued at $1,164,000. Royce & Associates LP acquired a new position in shares of Astrana Health in the 3rd quarter valued at about $6,661,000. Amalgamated Bank purchased a new stake in shares of Astrana Health in the third quarter worth about $713,000. Principal Financial Group Inc. purchased a new position in Astrana Health during the third quarter valued at approximately $13,383,000. Finally, Loomis Sayles & Co. L P acquired a new position in Astrana Health in the third quarter valued at approximately $30,251,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ASTH has been the topic of a number of analyst reports. Macquarie raised shares of Astrana Health to a “hold” rating in a research note on Monday, December 16th. Robert W. Baird lifted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Truist Financial lowered their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. BTIG Research lifted their price target on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Finally, KeyCorp started coverage on Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $63.67.

Astrana Health Trading Up 0.6 %

Shares of Astrana Health stock opened at $37.93 on Wednesday. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a twelve month low of $29.08 and a twelve month high of $63.20. The firm has a market capitalization of $2.13 billion, a PE ratio of 29.18, a P/E/G ratio of 1.46 and a beta of 1.20. The firm’s 50-day moving average price is $36.56 and its 200 day moving average price is $46.58.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $478.71 million for the quarter, compared to the consensus estimate of $462.01 million. During the same quarter last year, the business posted $0.47 earnings per share. On average, sell-side analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.